Christina Reith

15.6k total citations · 1 hit paper
30 papers, 5.4k citations indexed

About

Christina Reith is a scholar working on Economics and Econometrics, Surgery and Nephrology. According to data from OpenAlex, Christina Reith has authored 30 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Economics and Econometrics, 13 papers in Surgery and 7 papers in Nephrology. Recurrent topics in Christina Reith's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Lipoproteins and Cardiovascular Health (12 papers) and Pharmaceutical Economics and Policy (7 papers). Christina Reith is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Lipoproteins and Cardiovascular Health (12 papers) and Pharmaceutical Economics and Policy (7 papers). Christina Reith collaborates with scholars based in United Kingdom, Australia and United States. Christina Reith's co-authors include Jonathan Emberson, Colin Baigent, Anthony Keech, Lisa Blackwell, Neeraj Bhala, John Simes, R Peto, Elizabeth H Barnes, L E Holland and Martin Landray and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.

In The Last Decade

Christina Reith

30 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

2010 4.4k citations Colin Baigent, Lisa Blackwell et al. The Lancet profile →

Peers

Countries citing papers authored by Christina Reith

Since Specialization

Citations

This map shows the geographic impact of Christina Reith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Reith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Reith more than expected).

Fields of papers citing papers by Christina Reith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Reith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Reith. The network helps show where Christina Reith may publish in the future.

Co-authorship network of co-authors of Christina Reith

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Reith. A scholar is included among the top collaborators of Christina Reith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Reith. Christina Reith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study 2024 ·The Lancet Regional Health - Europe ·Borislava Mihaylova, (unknown), (unknown), Claire Williams, Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Richard J. Parnell, Jane Armitage, Alastair Gray, John Simes, Colin Baigent	11
2	Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study 2024 ·Heart ·Borislava Mihaylova, (unknown), (unknown), Claire Williams, Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Richard J. Parnell, Jane Armitage, Alastair Gray, John Simes, Colin Baigent	4
3	Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets 2024 ·Health Technology Assessment ·Borislava Mihaylova, (unknown), (unknown), (unknown), Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Richard J. Parnell, Jane Armitage, Alastair Gray, John Simes, Colin Baigent	2
4	Impact of Outcome Adjudication in Kidney Disease Trials: Observations From the Study of Heart and Renal Protection 2023 ·Kidney International Reports ·William G. Herrington, Charlie Harper, Natalie Staplin, Richard Haynes, Jonathan Emberson, Christina Reith, Lai Seong Hooi, Adeera Levin, Christoph Wanner, Colin Baigent, Martin Landray	1
5	Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK 2023 ·PharmacoEconomics ·(unknown), (unknown), Claire Williams, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, (unknown), Jane Armitage, Alastair Gray, John Simes, Colin Baigent, Borislava Mihaylova	10
6	Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model 2023 ·British Journal of General Practice ·(unknown), Claire Williams, (unknown), Iryna Schlackow, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Jane Armitage, Alastair Gray, John Simes, Colin Baigent, Borislava Mihaylova	5
7	Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials 2021 ·EClinicalMedicine ·Natalie Staplin, Alistair Roddick, Jonathan Emberson, Christina Reith, (unknown), Alexa Wonnacott, Apexa Kuverji, Sunil Bhandari, Colin Baigent, Richard Haynes, William G. Herrington	41
8	Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors 2020 ·Journal of the American College of Cardiology ·David Preiss, Jonathan A. Tobert, G. Kees Hovingh, Christina Reith	47
9	Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials 2018 ·The Lancet. Gastroenterology & hepatology ·(unknown), Jonathan Emberson, Enti Spata, Christina Reith, (unknown), Heather Halls, Lisa Holland, Kate Wilson, Neeraj Bhala, C J Hawkey, Marc C. Hochberg, Richard H. Hunt, Loren Laine, Ángel Lanas, Carlo Patrono, Colin Baigent	161
10	Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection 2017 ·BMC Nephrology ·(unknown), Christina Reith, Natalie Staplin, William G. Herrington, William Stevens, Jonathan Emberson, Richard Haynes, Marion Mafham, Jane Armitage, Alan Cass, Jonathan C. Craig, Lixin Jiang, Terje Pedersen, Colin Baigent, Martin Landray	10
11	Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials 2016 ·The Lancet Diabetes & Endocrinology ·(unknown), William G. Herrington, Jonathan Emberson, Borislava Mihaylova, Lisa Blackwell, Christina Reith, Marit D. Solbu, Patrick B. Mark, Bengt Fellström, Alan G. Jardine, Christoph Wanner, Hallvard Holdaas, Jordan Fulcher, Richard Haynes, Martin Landray, Anthony Keech, John Simes, Rory Collins	203
12	Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team 2016 ·Clinical Infectious Diseases ·Helen K. Donnelly, Demissie Alemayehu, (unknown), (unknown), Barry I. Eisenstein, (unknown), Kunal Merchant, Eric Pelfrene, Christina Reith, (unknown), Rosemary Tiernan, Richard G. Wunderink, Pamela Tenaerts, Charles Knirsch	4
13	Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection 2016 ·Nephrology Dialysis Transplantation ·Marion Mafham, Natalie Staplin, Jonathan Emberson, Richard Haynes, William G. Herrington, Christina Reith, Christoph Wanner, Robert Walker, Alan Cass, Adeera Levin, Bengt Fellström, Lixin Jiang, Hallvard Holdaas, Bertram L. Kasiske, David C. Wheeler, Martin Landray, Colin Baigent, (unknown)	8
14	Management of residual risk after statin therapy 2015 ·Atherosclerosis ·Christina Reith, Jane Armitage	69
15	What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? 2015 ·BMC Nephrology ·Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, Christina Reith, Jonathan Emberson, Richard Haynes, Alastair Gray, Alan Cass, Colin Baigent, Martin Landray, William G. Herrington, Borislava Mihaylova, (unknown)	79
16	The Effect of Lowering LDL Cholesterol on Vascular Access Patency 2014 ·Clinical Journal of the American Society of Nephrology ·William G. Herrington, Jonathan Emberson, Natalie Staplin, Lisa Blackwell, Bengt Fellström, Robert Walker, Adeera Levin, Lai Seong Hooi, Ziad A. Massy, Vladimı́r Tesař, Christina Reith, Richard Haynes, Colin Baigent, Martin Landray	18
17	Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) 2014 ·American Journal of Kidney Diseases ·Richard Haynes, Natalie Staplin, Jonathan Emberson, William G. Herrington, Charles Tomson, Lawrence Y. Agodoa, Vladimı́r Tesař, Adeera Levin, David Lewis, Christina Reith, Colin Baigent, Martin Landray	55
18	Pharmacogenomics of statin therapy 2014 ·Current Opinion in Lipidology ·Jemma C. Hopewell, Christina Reith, Jane Armitage	13
19	Randomized Clinical Trials — Removing Unnecessary Obstacles 2013 ·New England Journal of Medicine ·Christina Reith, Martin Landray, P.J. Devereaux, Jackie Bosch, Christopher B. Granger, Colin Baigent, Robert M. Califf, Rory Collins, Salim Yusuf	86
20	Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials breakdown → 2010 ·The Lancet ·(unknown), Colin Baigent, Lisa Blackwell, Jonathan Emberson, L E Holland, Christina Reith, Neeraj Bhala, R Peto, Elizabeth H Barnes, Anthony Keech, John Simes	4433

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact